RDY DR REDDYS LABORATORIES LTD
P/E
29.73
Forward P/E
27.03
Price/Sales
0.0329
Beta
0.25
Div Yield
0.0064%
Market Cap
--
Company Analysis
Latest News
Dr. Reddy's misses second quarter 2027 estimates as North America revenue declines 23%
Dr. Reddy's Laboratories reported second quarter 2027 financial results that missed analyst estimates for both revenue and earnings, primarily due to a sharp...
Dr. Reddy’s Laboratories Ltd Q3 2026 Earnings Preview: What Analysts Expect on October 23, 2026
Dr. Reddy's Laboratories is projected to report Q3 2026 revenue of $1.02 billion and an EPS of $0.16, while the stock currently trades at $17.42, roughly 14%...